重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

产品说明书

FAQ

COA

已发表文献

 

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses. The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Several emerging SARS-CoV-2 genomes have been identified including the Omicron, or B.1.1.529, variant. First identified in November 2021 in South Africa, the Omicron variant quickly became the predominant SARS-CoV-2 variant and is considered a variant of concern (VOC). The Omicron variant contains 15 mutations in RBD domain that potentially affect viral fitness and transmissibility. The majority of the mutations are involved in ACE-2 binding and Omicron binds ACE-2 with greater affinity, potentially explaining its increased transmissibility. Several of these mutations are also identified in facilitating immune escape and reducing neutralization activity to several monoclonal antibodies.    

 

产品性质

别名

S1 protein; Spike protein S1; Spike,S1 protein; S glycoprotein Subunit1

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-CoV-2 Spike S1 (Omicron BA.4/BA.5/BA.5.2) Protein is expressed from Expi293 with His tag at the C-terminal. It contains Gln14-Arg683(T19I, L24S, PPA25-27del, HV69-70del, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H).

分子量

Approximately 75.76 kDa. Due to glycosylation, the protein migrates to 100-120 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

活性

ELISA DataImmobilized SARS-CoV-2 Spike S1 (Omicron BA.4/BA.5/BA.5.2) , His Tag at 2μg/ml (100μl/Well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 85.6ng/ml determined by ELISA.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

冰袋运输。-20 ℃保存,一年有效期。

复溶后,-20 °C,在未开封状态下保存 3-6 个月。复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装冻存,避免反复冻融。

 

注意事项

  1. 避免反复冻融。
  2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。
  3. 本产品仅作科研用途!

HB221222

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

暂无内容

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

暂无内容

 

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses. The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Several emerging SARS-CoV-2 genomes have been identified including the Omicron, or B.1.1.529, variant. First identified in November 2021 in South Africa, the Omicron variant quickly became the predominant SARS-CoV-2 variant and is considered a variant of concern (VOC). The Omicron variant contains 15 mutations in RBD domain that potentially affect viral fitness and transmissibility. The majority of the mutations are involved in ACE-2 binding and Omicron binds ACE-2 with greater affinity, potentially explaining its increased transmissibility. Several of these mutations are also identified in facilitating immune escape and reducing neutralization activity to several monoclonal antibodies.    

 

产品性质

别名

S1 protein; Spike protein S1; Spike,S1 protein; S glycoprotein Subunit1

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-CoV-2 Spike S1 (Omicron BA.4/BA.5/BA.5.2) Protein is expressed from Expi293 with His tag at the C-terminal. It contains Gln14-Arg683(T19I, L24S, PPA25-27del, HV69-70del, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H).

分子量

Approximately 75.76 kDa. Due to glycosylation, the protein migrates to 100-120 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

活性

ELISA DataImmobilized SARS-CoV-2 Spike S1 (Omicron BA.4/BA.5/BA.5.2) , His Tag at 2μg/ml (100μl/Well) on the plate. Dose response curve for Human ACE2, hFc Tag with the EC50 of 85.6ng/ml determined by ELISA.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

冰袋运输。-20 ℃保存,一年有效期。

复溶后,-20 °C,在未开封状态下保存 3-6 个月。复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装冻存,避免反复冻融。

 

注意事项

  1. 避免反复冻融。
  2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。
  3. 本产品仅作科研用途!

HB221222

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

暂无内容

重组SARS-COV-2刺突S1蛋白(Omicron BA.4/BA.5/BA.5.2) His标签

暂无内容